Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300075429Phase 4Recruiting
Phase 4, randomised trial in thyroid neoplasm comparing Lidocaine group with Control group (normal saline placebo) (2 arms). Primary endpoint: Sleep assessment. Started Sep 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300075429.